Business
Currency:CNY
2024/H1
Stock NameRevenueRatio
销售生物制药产品2.48B90.33%
Research and development services251.01M9.15%
授权许可收入14.26M0.52%
Other85K0.00%
Product
No Data
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
Chinese mainland2.49B90.66%
North America182.71M6.65%
Europe66.33M2.42%
South America5.16M0.19%
Asia Pacific (excluding mainland China)2.17M0.08%
Oceania133K0.00%
View all